MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Sialorrhea"

  • 2019 International Congress

    Correlation Between Drooling and Quality of Life in Parkinson’s Disease

    O. Criciotoiu, D. Stanca, R. Latea, L. Giurgiulescu, A. Mita, V. Gheorman, D. Gheonea (Craiova, Romania)

    Objective: The aim of this study was to evaluate the relationship between the quality of life and drooling in Parkinson’s disease patients. Background: Parkinson’s disease…
  • 2018 International Congress

    Effects of Botulinum Toxin treatment for sialorrhea in patients with cerebral palsy

    J. Francês Brito, M. Akkari, A. Pinheiro Alves, A. Barbosa de Sousa Junior, B. De Oliveira, O. Vieira Kishi, Jose Roberto Bentes Capeloni (Belem, Brazil)

    Objective: To evaluate the benefits of treatment of drooling with Botulinum Toxin Type A (AbobotulinumtoxinA) in patients with cerebral palsy. Background: Patients with cerebral palsy…
  • 2018 International Congress

    Efficacy of incobotulinumtoxinA in patients with sialorrhea, as assessed using the modified Radboud Oral Motor Inventory for Parkinson’s disease (mROMP): Results of the SIAXI study

    W. Jost, A. Friedman, O. Michel, C. Oehlwein, J. Slawek, A. Bogucki, S. Ochudlo, M. Banach, F. Pagan, B. Flatau-Baqué, J. Csikós, A. Blitzer (Wolfach, Germany)

    Objective: The pivotal double-blind, randomised Phase III SIAXI study (NCT02091739), assessed the efficacy and safety of incobotulinumtoxinA 75 or 100 U for sialorrhea. Co-primary endpoints…
  • 2018 International Congress

    Long-term efficacy and safety of incobotulinumtoxinA treatment for sialorrhea in Parkinson’s disease and other neurologic conditions

    F. Pagan, W. Jost, A. Friedman, O. Michel, C. Oehlwein, J. Slawek, A. Bogucki, S. Ochudlo, M. Banach, B. Flatau-Baqué, J. Csikós, A. Blitzer (Washington, DC, USA)

    Objective: SIAXI (NCT02091739), a pivotal double-blind, randomised, placebo-controlled study with a 48-week extension period (EP), assessed the efficacy and safety of incobotulinumtoxinA 75 U or…
  • 2018 International Congress

    Impact of injection guidance techniques on the efficacy and safety of incobotulinumtoxinA for sialorrhea

    F. Pagan, W. Jost, A. Friedman, O. Michel, C. Oehlwein, J. Slawek, A. Bogucki, S. Ochudlo, M. Banach, B. Flatau-Baqué, J. Csikós, A. Blitzer (Washington, DC, USA)

    Objective: SIAXI (NCT02091739), a pivotal double-blind, randomised, placebo-controlled study with an extension period (EP), assessed the efficacy and safety of incobotulinumtoxinA 75 or 100 U…
  • 2017 International Congress

    Saliva changes and the oral health in Parkinson´s disease

    J. Tiigimäe-Saar, T. Tamme, P. Taba (Tartu, Estonia)

    Objective: The aim of this study was to determine the risk of change in the oral microflora and oral health in PD patients. Background: Parkinson…
  • 2017 International Congress

    The impact of divided attention in dual task conditions on drooling in Parkinson’s Disease (PD): a pilot study

    H. Reynolds, N. Miller, R. Walker (Gateshead, United Kingdom)

    Objective: To investigate whether frequency of saliva swallows reduced, and drooling severity and frequency increased, when people with PD engaged in a distracting cognitively demanding…
  • 2016 International Congress

    Awareness and perception of gastrointestinal symptoms in Parkinson´s disease: A survey of patients and caregiving relatives

    P. Themann (Halsbrücke, Germany)

    Objective: The purpose of this survey was to determine the awareness and perception of gastrointestinal (GI) symptoms in patients and caregiving relatives (for simplicity hereunder…
  • 2016 International Congress

    A comprehensive characterisation of the salivary proteome of patients with Parkinson’s disease

    J.M. Masters, A.J. Noyce, S. Lynham, T.T. Warner, G. Giovannoni, G.B. Proctor (Herts, United Kingdom)

    Objective: To comprehensively characterise the salivary proteome of patients with Parkinson's disease (PD) and generate potential biomarker candidates for future studies. Background: Saliva may be…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley